BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16613861)

  • 1. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation.
    Stojanovic A; Marjanovic JA; Brovkovych VM; Peng X; Hay N; Skidgel RA; Du X
    J Biol Chem; 2006 Jun; 281(24):16333-9. PubMed ID: 16613861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An important role of the SRC family kinase Lyn in stimulating platelet granule secretion.
    Li Z; Zhang G; Liu J; Stojanovic A; Ruan C; Lowell CA; Du X
    J Biol Chem; 2010 Apr; 285(17):12559-70. PubMed ID: 20189992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridoxine increases nitric oxide biosynthesis in human platelets.
    Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
    Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis.
    Lopes-Pires ME; Naime AC; Almeida Cardelli NJ; Anjos DJ; Antunes E; Marcondes S
    PLoS One; 2015; 10(9):e0137901. PubMed ID: 26375024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.
    Riba R; Sharifi M; Farndale RW; Naseem KM
    Thromb Haemost; 2005 Aug; 94(2):395-403. PubMed ID: 16113831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrovasodilators and cGMP inhibit human platelet activation.
    Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
    Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
    Han Y; Liu Y; Mi Q; Xie L; Huang Y; Jiang Q; Chen Q; Ferro A; Liu N; Ji Y
    Int J Vitam Nutr Res; 2010 Jun; 80(3):168-77. PubMed ID: 21234858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cGMP and cGMP-dependent protein kinase in platelets and blood cells.
    Walter U; Gambaryan S
    Handb Exp Pharmacol; 2009; (191):533-48. PubMed ID: 19089344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A platelet secretion pathway mediated by cGMP-dependent protein kinase.
    Li Z; Zhang G; Marjanovic JA; Ruan C; Du X
    J Biol Chem; 2004 Oct; 279(41):42469-75. PubMed ID: 15280395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
    Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I
    Thromb Haemost; 2017 Jun; 117(6):1115-1128. PubMed ID: 28405672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
    Isenberg JS; Romeo MJ; Yu C; Yu CK; Nghiem K; Monsale J; Rick ME; Wink DA; Frazier WA; Roberts DD
    Blood; 2008 Jan; 111(2):613-23. PubMed ID: 17890448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.
    Zhang G; Han J; Welch EJ; Ye RD; Voyno-Yasenetskaya TA; Malik AB; Du X; Li Z
    J Immunol; 2009 Jun; 182(12):7997-8004. PubMed ID: 19494325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    GĂ©linas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG.
    Zhai YK; Guo XY; Ge BF; Zhen P; Ma XN; Zhou J; Ma HP; Xian CJ; Chen KM
    Bone; 2014 Sep; 66():189-98. PubMed ID: 24956021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anandamide effect on NO/cGMP pathway in human platelets.
    Signorello MG; Giacobbe E; Passalacqua M; Leoncini G
    J Cell Biochem; 2011 Mar; 112(3):924-32. PubMed ID: 21328466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
    Schinner E; Salb K; Schlossmann J
    Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of nitric oxide and cGMP with signal transduction in activated platelets.
    Nguyen BL; Saitoh M; Ware JA
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
    Irwin C; Roberts W; Naseem KM
    Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells.
    Oliveira CJ; Schindler F; Ventura AM; Morais MS; Arai RJ; Debbas V; Stern A; Monteiro HP
    Free Radic Biol Med; 2003 Aug; 35(4):381-96. PubMed ID: 12899940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets.
    Kim S; Mangin P; Dangelmaier C; Lillian R; Jackson SP; Daniel JL; Kunapuli SP
    J Biol Chem; 2009 Dec; 284(49):33763-72. PubMed ID: 19700402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.